liraglutide glp 1 analogue is a GLP-1 analog used primarily in the treatment of diabetes 2 and obesity. The global sales of it in 2022 was USD 1.7 billion. Now we have launched this product GLP-1 Receptor Agonists | New

Chamoun K, Benton CB, AlRawi A, Jacamo R, Williams P, Wang F, Zhang J, Daver N, Kantarjian K, Konopleva M, Futreal A, Andreeff M

Controlled-release formulations represent another promising avenue for optimizing lithium orotate delivery

pmid:37732142 47

[PubMed: 33727283] [Free Article] Patel JP, Hardaswani D, Patel J, et al

The authors continued with the argument that supplementation with L-Carnitine could assist in the attainment of metabolic homeostasis, with some words of caution being sounded over the levels of D-Carnitine in certain supplements

In isolation, glucagon receptor activation would not be expected to serve as an ideal diabetes or obesity therapy